HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correction to "Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers".

AuthorsShujing Yue, Yifan Zhang, Yaohua Wei, Rainer Haag, Huanli Sun, Zhiyuan Zhong
JournalBiomacromolecules (Biomacromolecules) Vol. 23 Issue 12 Pg. 5373-5374 (Dec 12 2022) ISSN: 1526-4602 [Electronic] United States
PMID36351000 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: